Dow wins for the week, but not by much
The dicey markets resulted in a lot of stock winners and losers. Biotechs continued to get hammered with Gilead Sciences, (GILD, Fortune 500) Biogen Idec, (BIIB, Fortune 500)Celgene (CELG, Fortune 500) all closing sharply lower. Awful quarter for Best ...
TGIF as stocks up ahead of weekend
Stocks: A strong end to a 'meh' March?